Cash Runway: Extended into the third quarter of 2025, including net proceeds from recent capital raise. Warning! GuruFocus has detected 4 Warning Signs with INO. Release Date: May 13, 2024 ...

Good afternoon, ladies and gentlemen, and welcome to the INOVIO First Quarter 2024 Financial Results Conference Call. At this time all lines are in a listen-only mode. Following the presentation ...

Still, most of its programs haven't made it to phase 3 studies. It discontinued the development of its coronavirus vaccine, INO-4800, in the U.S. after encountering a range of clinical and ...

Do data resources managed by EMBL-EBI and our collaborators make a difference to your work? If so, please take 10 minutes to fill in our survey, and help us make the case for why sustaining open data ...

Analyst Stephens covers INOVIO Pharmaceuticals highlighting its diverse clinical pipeline and FDA's consideration of INO-3107 Phase 1/2 trials for Accelerated Approval. Potential as the first non ...

Internuclear ophthalmoplegia is a disturbance of coordinated eye movements, explains the NMSS. In this disorder, the eye develops nystagmus (shaky vision) when it turns outward to look to the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...